Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 11;9(2):e001646. doi: 10.1136/jitc-2020-001646

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Relationship between the expression of m⁶A regulators and immune cell infiltration. (A) Kaplan-Meier curves for patients with high or low IGF2BP3 expression in the TCGA-KIRC cohort. (B) The correlation between IGF2BP3 and the infiltration of Th2 cell in the TCGA-KIRC cohort (Left) and anti-PD-1 therapy cohort (Right). (C) Kaplan-Meier curves for patients with high or low Th2 cell infiltration in the TCGA-KIRC cohort. (D, E) Kaplan-Meier curves depicted the survival differences between patients with high and low IGF2BP3 expression (D) and Th2 cell infiltration (E) in the anti-PD-1 therapy cohort. m⁶A, N6-methyladenosine.